Eir Medical ApS: Financial statements 2022
CVR: 43033123
Source: annual report 2022, Danish Business Authority
04/02/2022 – 31/12/2022
Eir Medical ApS (CVR 43033123) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 469,941 and a net result of DKK 345,622. Equity in the 2022 report amounted to DKK 385,622. The solvency ratio was 42%.
- Gross Profit
- DKK 469,941
- Profit/Loss
- DKK 345,622
- Equity
- DKK 385,622
- Total Assets
- DKK 918,649
- Employees
- 0
Official annual report
Keep an eye on Eir Medical ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of February 4, 2022, Poul Kjædegaard Tølbøll is registered as director of Eir Medical ApS.
As of February 4, 2022, Worbech Holding ApS is registered as an owner of Eir Medical ApS with an ownership share of 50%.
As of February 4, 2022, Yggdrasil Tølbøll Holding ApS is registered as an owner of Eir Medical ApS with an ownership share of 50%.
Eir Medical ApS was founded on February 4, 2022.
About Eir Medical ApS
Eir Medical ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2022. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Poul Kjædegaard Tølbøll. The company is owned by Worbech Holding ApS and Yggdrasil Tølbøll Holding ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 2,157,811 and a net result of DKK 1,668,061 compared with DKK 509,341 the year before. Equity in the 2025 report amounted to DKK 3,208,438.